The Role of Immunity In Renal Disease & Transplantation Flashcards

1
Q

What is the immune complexes deposition?

A

Deposition of circulating immune complexes in the glomeruli, causing inflammation and glomerular damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are examples of immune complex deposition diseases?

A

SLE
IgA nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is molecular mimicry?

A

Antibodies generated against a foreign pathogen cross-react with kidney antigens, causing an autoimmune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are examples of diseases that portray molecular mimicry?

A

Post-streptococcal glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the direct autoimmune response?

A

Antibodies directly targeting kideny-specific antigens or autoantigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are examples of diseases where there is direct autoimmune response?

A

Primary membranous nephropathy (phospholipase A2 receptor, PLA2R-specific antibodies)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is antibody-mediated glomerular damage?

A

Formation of antibodies against podocyte antigens, leading to direct podocyte injury and proteinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are examples of diseases with antibody-mediated glomerular damage?

A

Minimal change disease (suspected immune-mediated injury to podocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is immune-mediated vasculitis?

A

Uncontrolled activation of the complement system, particularly the alternative complement pathway, leading to inflammation and tissue injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are example-disease of immune-mediated vasculitis?

A

Anti-neutrophil cytoplasmic-associated vasculitis (ANCA) (granulomatosis with polyangiitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is complement dysregulation?

A

Uncontrolled activation of the complement system, particularly the alternative complement pathway, leads to inflammation and tissue injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are examples of diseases with complement dysregulation?

A

Atypical Hemolytic Uremic Syndrome (aHUS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is cell-mediated immune response mechanism?

A

T-cells mediate immune responses that lead to localized inflammation and tissue injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are example diseases of cell-mediated immune response?

A

Acute interstitial nephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the mechanism of delayed-type hypersensitivity?

A

Direct action of sensitized T cells when stimulated by contact with antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are example-diseases of delayed-type hypersensitivity?

A

Allergic interstitial nephritis (commonly drug-induced)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the mechanism of innate immune activation via DAMPs?

A

Damage-associated molecular patterns released from injured kidney cells activate an immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are example diseases of innate-immune activation via DAMPs?

A

Ischemic acute kidney injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the immune response to infections?

A

Immune response against kidney infections caused by pathogen can lead to immune-mediated damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are example diseases of immune response to infections?

A

Bacterial pyelonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Which bacterium causes bacterial pyelonephritis?

A

E. coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is thrombotic microangiopathies mechanism?

A

Immune-mediated injury to the microvasculature, leading to thrombosis and tissue ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are examples diseases of thrombotic microangiopathy mechanisms?

A

Shiga-toxin-producing E. coli-induced hemolytic uremic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the proteinuria-induced inflammation mechanism?

A

Increased levels of protein in the urine induce a stress response in the tubular cells, triggering inflammation and tubulointerstitial damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are example diseases of proteinuria-induced inflammation?

A

Focal segmental glomerulosclerosis (FSGS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What can be transplated? (5)

A
  1. Blood/products
  2. Whole organs
  3. Partial organs
  4. Cells & Tissues
  5. HCT (hematopoietic cell transplantation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are pre-transplant procedure that the recipient receives?

A

Dialysis
LVAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are intra-operative procedures the recipient receives?

A

Surgery Cardiopulmonary Bypass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are post-operative consequences to the recipient?

A

Reperfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the complications that the recipient might face?

A

Acute Rejection (acute)
Infection
Injury Repair (chronic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

In the example HLA-A* 24020102L what does A signify?

A

Locus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

In the example HLA-A* 24020102L what does * signify?

A

Signifies DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

In the example HLA-A* 24020102L what does “24” signify?

A

Type, corresponds to the serologic antigen or family

34
Q

In the example HLA-A* 24020102L what does the first “02” signify?

A

Subtype

35
Q

In the example HLA-A* 24020102L what does “01” signify?

A

Silent substitution

36
Q

In the example HLA-A* 24020102L what does the second “02” signify?

A

Differences outside the coding region (introns)

37
Q

In the example HLA-A* 24020102L what does “L” signify?

A

Expression

38
Q

When may an SNP appear twice?

A

If it has been associated with more than one disease

39
Q

What are the different types of allograft rejection?

A
  1. Hyperacute rejection
  2. Accelerated rejection
  3. Acute rejection (acute humoral and acute cellular)
  4. Chronic rejection
40
Q

What is hyperacute graft rejection like?

A
  1. Normal kidney grafted into a patient with defective kidney and pre-existing antibodies against donor blood group antigens
  2. Antibodies against donor blood group antigens bind the vascular epithelium of the graft initiating an inflammatory response, which occludes blood vessels
  3. Graft becomes engorged and purple-coloured because of the hemorrhage
41
Q

Which immune response is initiated during the hyperacute graft rejection, and how fast?

A

Complement mediated reaction within MINUTES of transplantation

42
Q

What causes the hyper-acute graft rejection?

A

Pre-existing alloantibodies against blood group antigens or MHC antigens

43
Q

What is the mechanism of Hyperacute rejection?

A

Preformed antibodies react with:
1. alloantigens on the vascular epithelium on the graft
2. activate complement
3. trigger rapid intravascular thrombosis and necrosis of the vessel wall

44
Q

What is the mechanism of acute rejection?

A

In acute cellular rejection:
1. CD8+ T lymphocytes reactive with alloantigens on graft endothelial cells and parenchymal cells cause damage to these cell types.

45
Q

What is endothelium inflammation called?

A

Endothelialitis

46
Q

Which kind of antibodies may also contrubute to vascular injury?

A

Alloreactive antibodies

47
Q

How long after the transplant does hyperacute rejection occur?

A

Less than 24 hours

48
Q

What are the signs and symptoms of hyperacute rejection?

A

Fever and anuria

49
Q

WHat is the immune component of hyperacute rejection?

A

Antibody and complement

50
Q

What are the pathological findings of hyperacute rejection?

A

Polymorphonuclear neutrophil deposition and thrombosis

51
Q

What is the treatment for hyperacute rejection?

A

None, success rate –> 0%

52
Q

How long after transplantation does accelerated rejection occur?

A

3 to 5 days

53
Q

What are the signs and symptoms of accelerated rejection?

A

Fever, graft swelling, oliguria, tenderness

54
Q

What is the immune component of the accelerated rejection?

A

Non-complement fixing antibodies

55
Q

What are the pathological findings of accelerated rejection?

A

Vascular disrpution hemorrhage

56
Q

What is the treatment for accelerated rejection?

A

ALF, ATG and anti-CD3, success rate –> 60%

57
Q

How long after transplantation does acute reaction occur?

A

6 to 90 days

58
Q

What are the signs and symptoms of acute rejection?

A

Oliguria
Salt retention
Graft swelling
Tenderness
Sometimes fever

59
Q

What is the immune complement of acute rejection?

A

T cells and antibodies

60
Q

What are the pathologic findings of acute rejection?

A

Tubulitis and endovasculitis

61
Q

What is the treatment for acute rejection?

A

Steroids, ALG, ATG and anti-CD3, success rate –> 60 to 90%

62
Q

How long after tranplantation does chronic rejection occur?

A

More than 60 days

63
Q

What are the signs and symptoms of chronic rejection?

A

Edema
Hypertension
Proteinuria
Occasional hematuria

64
Q

What is the immune component of chronic rejection?

A

Antibody

65
Q

What are the pathologic findings of chronic rejection?

A

Vascular onion skinning

66
Q

What is the treatment for chronic rejection?

A

None, success rate –> 0%

67
Q

What is operational tolerance?

A

The specific absence of a destructive immune response to transplanted tissues without maintenance immunosuppression

68
Q

What are the approaches to tolerance induction?

A

Microchimerism
T-Regulatory

69
Q

What are the three essential requirements of Graft vs. Host Disease?

A
  1. The graft must contain immune complement cells
  2. The host must be recognized by the graft as foreign
  3. The host must be incapable of rejecting the graft before it mounts an effective immune response
70
Q

What prevents GVHD?

A

T-cell depletion in donor grafts prevents GvHD and thus decreases morbidity and mortality

71
Q

What are minor HC Antigens?

A

Minor histocompatibility antigens are human-leukocyte antigen-presented peptides derived from normal self-proteins that differ in amino acid sequence between donor and recipient due to genetic polymorphisms

72
Q

Where are minor H antigens expressed?

A

Epithelial tissue and hematopoietic cells

73
Q

What happens if donor T cells recognize minor H antigens?

A

Graft vs Host disease
Graft vs. Leukemia

74
Q

What can some minor H antigens be used as?

A

Therapeutic T-cell targets augment the graft vs. leukemia effect in order to prevent or manage leukemia relapse after HCT

75
Q

What happens to the patient’s normal hematopoietic and leukemia cells with minor H antigens?

A

They are eliminated by the transplant conditioning regimen and replaced with donor hematopoietic cells

76
Q

What happens if all of the patient’s normal hematopoietic and leukemia cells with minor H antigens are chimerised?

A

The patient is cured

77
Q

What happens if the recipient’s malignant hematopoietic cells present hematopoietic-restricted minor H?

A

The disease persists or reoccurs and the patient relapses

78
Q

What do the minor H antigens serve as?

A

Tumor-specific antigens for donor T cells

79
Q

How do we match donors to recipients?

A

HCT: high-resolution HLA matching
Solid organ transplants:
1. Avoid unacceptable incompatibility (ABO Blood group + Avoid preformed HLA antibodies)
2. Maximize HLA compatibility

80
Q
A